Alteogen Enters License Deal With Daiichi Sankyo For ALT-B4 In Subcutaneous ENHERTU Development
Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...
Case study describes potential breakthrough in treatment of aggressive type of prostate cancer
Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a case ...
pharmaphorum5d
Seagen wins Enhertu patent dispute with Daiichi Sankyo
Seagen claims Enhertu (trastuzumab deruxtecan) – an antibody-drug conjugate (ADC) targeting HER2 – infringes a patient it holds (No. 10,808,039) covering ADCs that include auristatin compounds ...
pharmaphorum1d
AZ and Daiichi's TROP2 ADC shows promise in first-line lung cancer
The results suggest that AZ and Daiichi Sankyo could be in line for a second big win for a cancer ADC to follow Enhertu (trastuzumab deruxtecan), their HER2-directed drug which has just claimed a ...
BioWorld3d
First-in-class dual-payload anti-HER2 agent presented
Anti-HER2 antibody-drug conjugates (ADCs) have proven effective in multiple tumor types. However, between 64% and 85% of HER2+ breast and gastric cancer patients retain HER2 expression after treatment ...
Medscape2d
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study
Trastuzumab, tested only as a single agent, has been shown to achieve 7% response in heavily pretreated patients with AOC with 3+ and 2+ HER2 immunostaining by immunohistochemistry (IHC).
Deutschlandfunk6d
Trump vs. Harris: Wer zieht ins Weiße Haus?
Der Name, bestehend aus dem lateinischen salve/retten und sanus/gesund sowie einem Rest des Wortes Arsen weist auf die Wirkweise hin: heilendes Arsen; der Wirkstoff: Arsphenamin. Es war lange das ...
welt.de5d
betreut den Bereich „Reinigung“
Als Autor und Bastelfan freue ich mich darauf, meine Leidenschaft für das Schreiben und meine Expertise im Bereich Bastelbedarf zu kombinieren. Durch meine Arbeit als Autor im Bastelbereich habe ...
Daily3d
CDSCO panel Approves AstraZeneca's Protocol Amendment proposal for Datopotamab Deruxtecan study
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's protocol amendment proposal to study anticancer drug ...
verywellhealth5d
The Most Effective HER2-Positive Breast Cancer Treatments
In 2019 the FDA approved Enhertu (fam-trastuzumab-deruxtecan-nxki) to treat adults with certain types of HER2-positive breast cancer. In 2022, the FDA expanded the use of Enhertu to treat ...
rbb6d
Folge 3: Ziel vor Augen
In der dreiteiligen Doku treffen sich vier Frauen, die ein Thema vereint: die Wechseljahre. Sie sprechen darüber in der Sauna - offen, authentisch und ohne Tabus. Jede hat ihre persönliche ...